ATC Group: L04AD02 Tacrolimus

Anatomical Therapeutic Chemical Classification System

Hierarchical position in ATC classification

Level
Code
Title
1
Antineoplastic and immunomodulating agents
2
Immunosuppressants
3
Immunosuppressants
4
Calcineurin inhibitors
5
L04AD02
Tacrolimus

Active ingredients

Active Ingredient
Description

Tacrolimus is a highly potent immunosuppressive agent. In particular, tacrolimus inhibits the formation of cytotoxic lymphocytes, which are mainly responsible for graft rejection. Tacrolimus suppresses T-cell activation and T-helper-cell dependent B-cell proliferation, as well as the formation of lymphokines (such as interleukins-2, -3, and γ-interferon) and the expression of the interleukin-2 receptor.

Medicines in this ATC group

Drug
Countries

France Italy Spain United Kingdom

Austria Finland Netherlands

Australia Austria Canada Cyprus Finland ...

Italy Spain

Austria Finland Lithuania Netherlands Poland ...

Austria Canada Finland France Ireland ...

South Africa

South Africa

Austria Finland France Ireland Lithuania ...

South Africa

Australia

Australia Austria Brazil Canada Cyprus ...

Netherlands

Austria Ireland Italy Lithuania Poland ...

Austria Italy Poland Spain

Australia

Brazil

Related product monographs

Title
Type
Country
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
IE